Insights

Latest developments in the ClinTex world.

12/11/2019

Driving Innovation: Blockchain Adoption For Clinical Trials Optimization

Blockchainnews

Pharmaceutical companies and research institutions are feeling the pressure to reduce the time, financial, and other resource costs associated with conducting clinical trials. With the influx of…

Read more
02/07/2019

ClinTex and Intellimed Renew Partnership

Clinical Trials Intelligencenews

ClinTex areare please to announce the renewal of their partnership with Intellimed. Intellimed is an innovative health-tech company focusing on streamlining UK National Health Service (NHS)…

Read more
15/09/2018

CTi Development reaches key milestone

Big DataBlockchainClinical Trials Intelligencenews

ClinTex are delighted to announce that the CTi Platform has reached a key development milestone this month. Both the CTi Data Model design and the CTi-OEM app have reached…

Read more
20/03/2018

Cognoa’s AI platform for autism diagnosis gets first FDA stamp

datanews

Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an…

Read more
15/03/2018

Pharma the next industry to embrace blockchain?

Blockchainnews

The mainstream press headlines are full these days of the tales of possibilities offered by blockchain technology. But actually, on the ground, it takes a certain entrepreneurial spirit to instigate a…

Read more
12/03/2018

Big Pharma Seeks DLT Solution for Drug Costs

news

What if blockchain could be used to actually save lives? That’s the thinking ongoing at pharmaceutical heavyweights Pfizer, Amgen and Sanofi. The three companies – typically black boxes…

Read more
08/03/2018

Regulatory Recognition – Cognoa

news

Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an…

Read more
08/03/2018

Roche To Buy Big Data Upstart Flatiron Health For $1.9 Billion

news

Roche, the Swiss drug giant, will buy New York-based Flatiron Health, which has become a leader in applying big data approaches to medicine, for $1.9 billion. Roche already owned a 12% stake in…

Read more